A detailed history of Newbridge Financial Services Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 135 shares of EW stock, worth $8,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares
135
Previous 409 66.99%
Holding current value
$8,888
Previous $39,000 69.23%
% of portfolio
0.0%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

SELL
$84.3 - $94.31 $23,098 - $25,840
-274 Reduced 66.99%
135 $12,000
Q1 2024

Apr 24, 2024

SELL
$72.54 - $95.56 $142,758 - $188,062
-1,968 Reduced 82.79%
409 $39,000
Q4 2023

Mar 28, 2024

SELL
$61.71 - $77.76 $8,392 - $10,575
-136 Reduced 5.41%
2,377 $181,000
Q3 2023

Oct 17, 2023

BUY
$69.28 - $93.38 $2,424 - $3,268
35 Added 1.41%
2,513 $174,000
Q2 2023

Jul 21, 2023

BUY
$81.41 - $94.33 $1,058 - $1,226
13 Added 0.53%
2,478 $233,000
Q1 2023

Apr 18, 2023

SELL
$74.26 - $84.51 $1,039 - $1,183
-14 Reduced 0.56%
2,465 $203,000
Q4 2022

Jan 17, 2023

BUY
$68.3 - $87.44 $1,844 - $2,360
27 Added 1.1%
2,479 $0
Q3 2022

Oct 13, 2022

SELL
$82.37 - $107.29 $1,317 - $1,716
-16 Reduced 0.65%
2,452 $203,000
Q2 2022

Jul 15, 2022

BUY
$86.5 - $128.27 $11,418 - $16,931
132 Added 5.65%
2,468 $235,000
Q1 2022

Apr 26, 2022

BUY
$101.96 - $128.34 $6,525 - $8,213
64 Added 2.82%
2,336 $275,000
Q4 2021

Jan 19, 2022

BUY
$106.37 - $130.68 $220,185 - $270,507
2,070 Added 1024.75%
2,272 $294,000
Q3 2021

Oct 27, 2021

SELL
$102.91 - $122.75 $6,174 - $7,365
-60 Reduced 22.9%
202 $23,000
Q2 2021

Sep 07, 2021

SELL
$83.84 - $104.76 $4,192 - $5,238
-50 Reduced 16.03%
262 $27,000
Q1 2021

Sep 07, 2021

SELL
$78.68 - $90.67 $9,441 - $10,880
-120 Reduced 27.78%
312 $26,000
Q4 2020

Sep 07, 2021

SELL
$71.69 - $91.23 $21,507 - $27,369
-300 Reduced 40.98%
432 $39,000
Q3 2020

Sep 07, 2021

BUY
$67.19 - $87.44 $49,183 - $64,006
732 New
732 $58,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.